Skip to main content
Clinical Trials/NCT01590251
NCT01590251CompletedPhase 1

Yoga for Pain and Opioid Dependence

Yale University2 sites in 1 country8 target enrollmentStarted: April 2012Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
8
Locations
2
Primary Endpoint
Reduce illicit opioid use

Study Overview

Brief Summary

This study is designed to develop an effective adjunctive treatment using yoga for chronic pain and opioid dependence.

Detailed Description

This study aims to develop an adjunctive novel treatment intervention using yoga in opioid agonist maintained patients to effectively treat the co-occurring disorders of non-malignant chronic pain and opioid dependence (POD).

Specific Aims:

  1. To conduct a pre-pilot phase with 8 patients with POD receiving opioid agonist maintenance treatment.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 18 years of age or older
  • Prescription opioid addiction or heroin addiction
  • Moderate to severe chronic pain,
  • Understands English

Exclusion Criteria

  • Current suicide or homicide risk
  • Life threatening or unstable medical condition
  • Medical or psychiatric condition that is judged to be of clinical concern by the PI or admitting clinician
  • Pregnancy

Outcomes

Primary Outcomes

Reduce illicit opioid use

Time Frame: 8 weeks

Reduced illicit opioid use will be measured by patient self-report and urinalysis testing.

Pain reduction

Time Frame: 8 weeks

Pain reduction will be measured by patient self-report using standard pain rating scales.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Yoga for Pain and Opioid Dependence | Clinical Trial